Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Comorbid illnesses

Heart transplantation represents the final option for refractory, end-stage HF patients who have exhausted medical and device therapies. Heart transplantation is not a cure, but should be considered a trade between a life-threatening syndrome and the risks associated with the operation and long-term immunosuppression. Assessment of appropriate candidates includes comorbid illnesses, psychosocial behavior, available financial and social support, and patient willingness to adhere to lifelong therapy and close medical follow-up.1 Overall, the transplant recipient s quality of life may be improved, but not all patients receive this benefit. Posttransplant survival continues to improve due to advances in immunosuppression, treatment and prevention of infection, and optimal management of patient comorbidities. [Pg.59]

Uncomplicated exacerbation Not requiring hospitalization Less than 3 exacerbations per year No comorbid illness I I V, greater than 50% predicted No recent antibiotic therapy Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis Oral Macrolide (azithromycin, clarithromycin) Second- or third-generation cephalosporin (cefuroxime, cefpodoxime, cefdinir, cefprozil) Doxycycline Ketolide (telithromycin) P-Lactam/P-Iactamase inhibitor (amoxicillin-clavulanate) Intravenous Not recommended... [Pg.241]

Psoriasis is a common inflammatory skin disorder which is estimated to affect 1.5% to 3% of the Caucasian population.1,2 It may present at any age.3,4 Ethnic factors influence disease prevalence. In the United States, prevalence among blacks (0.45% to 0.7%) is lower than in the remainder of the United States population (1.4% to 4.6%).1 Between 10% and 30% of patients with psoriasis will also have psoriatic arthritis.5 In 10% to 15% of psoriatic patients with arthritis, joint symptoms actually appear prior to skin involvement.3 Clinical depression is another frequent comorbid illness in these patients. A recent United States survey showed that 8% to 10% of psoriatic patients aged 18 to 54 years old actively contemplated suicide because of their psoriasis.6... [Pg.950]

The hrst-line treatments for panic disorder are (1) cognitive-behavioral therapy (CBT), (2) benzodiazepines, and (3) SSRIs/SNRls. Each of these three treatment modalities can be nsed independently or in combination. The selection of the primary treatment depends on several factors inclnding severity and frequency of the panic attacks, comorbid illnesses, and patient preference. [Pg.144]

There are two principal disadvantages of buspirone therapy. First, it must be administered two or three times daily. Long-term patient compliance is notoriously poor for medications that cannot be administered in a single daily dose. Second, buspirone is not an effective treatment for depression or any of the other comorbidities that frequently accompany GAD. As a result, buspirone monotherapy is only an alternative for GAD patients who have no comorbid illness. [Pg.150]

First-line GAD treatments include (1) cognitive-behavioral therapy (CBT), (2) antidepressants, (3) buspirone, and (4) benzodiazepines. Treatment selection is determined by the severity of the illness, the presence of any comorbid illnesses, previous patient treatment responses, and patient preference. When treating mild GAD, we recommend eschewing psychotropic medication altogether in favor of CBT. Moderate-to-severe GAD usually requires pharmacotherapy, though combined CBT-pharmacotherapy is highly encouraged. [Pg.151]

Patients with social anxiety disorder often come to clinical attention as a result of other frequent comorbid illnesses. In particular, those with social anxiety disorder... [Pg.160]

Although depression is the most prominent comorbid illness, a variety of other psychiatric conditions may be associated with panic disorder, for example, agoraphobia [60% of patients with panic disorder], other anxiety disorders (20%), and drug and alcohol abuse [15%] [Klerman 1992). [Pg.368]

Lifestyle factors have been associated with ED in both cross-sectional and longitudinal studies. In particular, obesity and sedentary lifestyle are clear-cut risk factors for ED, both in men with comorbid illnesses such as hypertension and diabetes, and especially in men without overt cardiovascular disease (50). Other lifestyle factors, such as smoking and alcohol consumption, have been implicated in some, but not all, studies to date. Intervening on cardiovascular and lifestyle factors may have broader benefits beyond restoration of erectile function. This important concept needs careful consideration, as recent studies have implicated the role of the metabolic syndrome, obesity, insulin resistance, and lack of exercise as independent risk factors for both ED and cardiovascular disease (51,52). [Pg.510]

In severely ill, elderly, pregnant, or immunocompromised patients, or those having an underlying comorbid illness... [Pg.62]

Ciccone DS, Natelson BH. Comorbid illness in women with chronic fatigue syndrome A test of the single syndrome hypothesis. Psychosomatic Med 2003 65 268-75. [Pg.456]

No comorbid illness M. catarrhalis Second- or third-generation... [Pg.552]

Life expectancy less than 1 year or severe comorbid illness or CMO on admission Additional warnings for patients treated within 3-4.5 h Age >80... [Pg.234]

Only a small percentage of patients require ventilation for at least six hours per day for 21 days (2 These patients are often older, have more comorbid illnesses, and, liequendy, have underlying obstmetive lung disease (3,4). Patients who have had a shorter duration of mechanical ventilatory support during surgery are more likely to be successfully weaned (5,6). [Pg.93]

It has been proposed that the presence of comorbid illness among patients with MCS, CFS, and FM supports a single syndrome hypothesis, i.e., that all are variants of a single functional disorder [79]. This is supported by the nitric oxide/peroxyni-trite hypothesis that has been previously discussed [26, 49-52] and by the shared symptoms in Gulf War veterans [73, 74]. It is argued here, however, that though these illnesses have overlapping symptoms, this hypothesis is yet to be definitively proven. Each of the illnesses has distinct differences from the others and at least one, MCS, demonstrates a resolution of symptoms when exposures to the causative chemicals are eliminated. [Pg.379]


See other pages where Comorbid illnesses is mentioned: [Pg.40]    [Pg.607]    [Pg.166]    [Pg.239]    [Pg.135]    [Pg.162]    [Pg.205]    [Pg.447]    [Pg.107]    [Pg.161]    [Pg.91]    [Pg.174]   
See also in sourсe #XX -- [ Pg.174 ]




SEARCH



Comorbidities

Comorbidity

© 2024 chempedia.info